overview - indirect cholinergic agonism (ache inhibition) - muscarinic antagonism (emphasis on drugs...

27
Overview • - Indirect cholinergic agonism (AchE inhibition) • - Muscarinic antagonism (emphasis on drugs and organ effects) • - Nicotine-Ach receptor (emphasis on drugs and therapeutics)

Upload: tamsyn-shields

Post on 03-Jan-2016

222 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Overview

• - Indirect cholinergic agonism (AchE inhibition)

• - Muscarinic antagonism (emphasis on drugs and organ effects)

• - Nicotine-Ach receptor (emphasis on drugs and therapeutics)

Page 2: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Indirect cholinergic agonists

Inhibitors of acetylcholinesterase

-Increase acetylcholine concentration and lifetime by inhibiting degradation

-Act by binding to AchE active site causing reversible(non covalent) or long lasting (covalent modification)

Page 3: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Mechanisms of indirect agonism

- Quaternary alcohols (ephodronium) – reversible binding (limit acetylcholine access)

Non covalent – enzyme-inhibitor complex lifetime (2 - 10 minutes)

- Carbamate esters – neostigmine, physostigmine – reaction with AchE active site

Covalent carbamoylation – enzyme-inhibitor complex lifetime (0.5 - 6h)

- Organophosphates – Parathion, Sarin, Soman - phophorylates AchE active site

Covalent phosphorylation – very stable enzyme-inhibitor complex, days (especially after aging)

Page 4: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

AchE Inhibitors (quaternary alcohols and carbamates)

Page 5: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Organophosphates

Page 6: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Aging

Page 7: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Organ effects/therapeutic uses

• - Effects are due to acetylcholine accumulation and are both sympathetic and parasympathetic

USES Approx DurationALCOHOLS

Edrophonium Myasthenia gravis 5 – 15 minutesarrythmias

CARBAMATES

Neostigmine Myasthenia gravis 0.5 – 2hPyridostigmine Myasthenia gravis 3 – 6hPhysostigmine Glaucoma 0.5 – 2hDemecarium Glaucoma 4 – 6h

Organophosphates

Echotiophate Glaucoma 100 h (> 4 days)

Page 8: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Treatment of organophosphate poisoning

• 1 - maintenance of vital signs (respiration particularly important)

• 2 - Decontamination (to avoid further absorption)

• 3 - Atropine parenterally (to minimize muscarinic effects) as required

• 4 - Rescue of AchE activity with Hydroxylamines (Pralidoxime, Diacetylmonoxime)

Page 9: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Muscarinic antagonism

Attropa belladona

Page 10: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Muscarinic Antagonists

ATROPINE

SCOPOLAMINE

Page 11: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Muscarinic Antagonists

ATROPINE

SCOPOLAMINE Attropa belladona

- Atropine and Scopolamine are belladona alkaloids (competitive inhibitors)

-Drugs differ in their CNS effects, scopolamine permeates the blood-brain barrier

-At therapeutic doses atropine has negligible effects upon the CNS, scopolamine even at low doses has prominent CNS effects.

Page 12: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Mechanism of drug action

- Competitively block muscarinic receptors

- Salivary, bronchial, and sweat glands aremost sensitive to atropine

- Smooth muscle and heart are intermediatein responsiveness

- In the eye, causes pupil dilation and difficulty for far vision accomodation

- Relaxation of the GI, slows peristalsis

Page 13: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

History/sources

• Atropa belladona - used in the renaissance• Deadly nightshade - used in the middle ages to produce prolonged

poisoning

Jimson plant leaves burned in India to treat Asthma (1800) purification of atropine (1831)

Page 14: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Effect of muscarinic inhibitor in the eyePupil dilation vs accomodation

Page 15: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Effect of muscarinic inhibition in the heart and salivary glands

- Increases the heart rate after a transient bradychardia at the low dose- Diminishes gland excretory function

Page 16: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Graphic summary of atropine effects

Page 17: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Organ effect – drug reviewAntidotes

• ORGAN DRUG APPLICATIONCNS Benztropine Treat Parkinson’s disease

Scopolamine Prevent/Reduce motion sickness

Eye Atropine Pupil dilation

Bronchi Ipatropium Bronchodilate in Asthma, COPD

GI Methscopolamine Reduce motility/cramps

GU Oxybutinin Treat transient cystitisPostoperative bladder spasms

Page 18: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Toxicity of muscarinic antagonists

• “DRY AS BONE, RED AS A BEET, MAD AS HATTER.”

• Dry is a consequence of decreased sweating, salivation and lacrimation

• Red is a result of reflex peripheral (cutaneous) vasodilation to dissipate heat (hyperthermia)

• Mad is a result of the CNS effects of muscarinic inhibition which can lead to sedation, amnesia (hypersensitivity), or hallucination

Page 19: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Nicotinic – Acetylcholine Receptor

polarizedRelaxation

depolarizedcontraction

Page 20: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Signaling through Ach-nicotinic receptor(competitive and depolarizing blockers)

Page 21: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Competitive/depolarizing

CompetitivePhysically blocks Ach binding

INHIBITOR

DepolarizingBinds and locks the receptoropen

Page 22: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Examples of competitive/depolarizing drugs

Competitive

Tubocurarine Mivacurium

Depolarizing

AchEButyrylcholinesteraseSensitive sites

Succinylcholine

Page 23: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Clinical uses

• Adjuvant use in surgical anesthesia (muscular relaxation)

• Advantage – much lighter levels of anesthesia required

• Other uses: muscular relaxation for orthopedics (correction of dislocation/alignment of fractures)

• (short duration) – facilitate intubation, laryngoscopy, bronchoscopy, esophagoscopy

• Control of muscular spasms, strabism, hemifacial spasms, oromandibular and cervical dystonia, spasms of the lower esophageal sphincter

• Cosmetic – Bottox (Botulinum toxin A)

• Paralytic action on skeletal muscle

Page 24: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Agents/Features/Duration

• AGENT CLASS PROPERTY ONSET DURATION Succinylcholine Dicholine ester Depolarization 1 min 5 – 8 min

Tubocurarine Alkaloid Competitive 5 min 80 – 120 min

Atracurium Benzylisoquinoline Competitive 3 min 30 – 60 min

Mivacurium Benzylisoquinoline Competitive 3 min 12 – 18 min

Pancuronium Ammonio Steroid Competitive 5 min 120 – 180 min

Vecuronium Ammonio Steroid Competitive 3 min 60 – 90 min

Hydrolysis by esterases Liver clearance/renal elimination Both

Page 25: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Precautions/Toxicity

• - Prolonged apnea, cardiovascular collapse

Sequence of paralysis : Eye muscles, Jaw, Larynx, limbs and trunk, intercostal muscles and the dyaphragm

- Generally caused by diminished esterase activity, renal malfunction, liver insufficiency, poor circulatory function.

- Special caution in patients with electrolyte imbalance (K+)

- Antidote : Neostigmine/Ephodronium to increase Ach, and atropine to block Ach muscarinic stimulation.

- Malignant hyperthermia – results from a discharge of Ca2+, exacerbated muscular action – tachycardia, hyperthermia, acidosis and rigidity (mutations of RYR1, central core disease) treated with Dantrolene, preservation of respiration

Page 26: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Summary

X

TetrodoxinBatrachotoxin

XHemicholiniumBotulinum toxin

XCurare alkaloidsSnake venom α

XAch

HydrolysisAchE inhibitors

XDantrolene

AchpilocarpineMuscarineBethanecholNeostigmine**Edrophonium**

X

** Indirect

AtropineScopolamineTubocurarineMivacurium

Page 27: Overview - Indirect cholinergic agonism (AchE inhibition) - Muscarinic antagonism (emphasis on drugs and organ effects) - Nicotine-Ach receptor (emphasis

Movie

http://www.youtube.com/watch?v=yd46Hs7pTowNicotine in the brain